A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CDGE / constant denaturant gel electrophoresis

[Related PubMed/MEDLINE]
Total Number of Papers: 35
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CDGE  (>> Co-occurring Abbreviation)
Long Form:   constant denaturant gel electrophoresis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2005 Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis. DGGE, TTGE
2003 Identification of parental origin of cognate dsRNA genome segment(s) of rotavirus reassortants by constant denaturant gel electrophoresis. ds, PAGE
2003 [Integrin Beta 3 PlA1/PlA2 polimorphism does not contribute to complications in both type 1 and type 2 diabetes]. BR, CHD, HYP, MA, PR
2001 Detection of mutations by denaturing gradient gel electrophoresis. DGGE
2000 Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism. PTT, REF-SSCP
2000 Monitoring Piscirickettsia salmonis by denaturant gel electrophoresis and competitive PCR. DGGE, ITS, rRNA
2000 Mutation detection in the breast cancer gene BRCA1 using the protein truncation test. HD, PTT, SSCP
2000 RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. HSCR
1999 Improved mutation detection in GC-rich DNA fragments by combined DGGE and CDGE. DGGE
10  1999 TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas. IHC, PCR
11  1999 [Blood-group genotyping by constant denaturing gel electrophoresis (CDGE)]. ---
12  1998 Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. ---
13  1998 Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load. HPV, IHC
14  1997 Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis. AI, HSR, PCR
15  1997 Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. IHC
16  1997 Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families. ---
17  1996 TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast. DCIS
18  1996 TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material. ---
19  1995 Comparison of DGGE and CDGE in detection of single base changes in the hamster hprt and human N-ras genes. DGGE, HPRT
20  1995 Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. HNPCC
21  1995 TP53 gene mutations and protein accumulation in primary vaginal carcinomas. ---
22  1995 TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue. ---
23  1994 Absence of p53 mutations and various frequencies of Ki-ras exon 1 mutations in rat hepatic tumors induced by different carcinogens. 3'-Me-DAB, AFB1, DEN, DGGE, HCCs, NMU, PCR
24  1994 Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. LFS, PCR
25  1994 p53 alterations in gastric carcinoma: a study of 56 primary tumors and 204 nodal metastases. ---
26  1993 Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. HOT, SSCP
27  1993 Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. AI, HPV, PCR
28  1993 No germline TP53 mutations detected in familial and bilateral testicular cancer. DGGE, GCT, LOH, PCR
29  1993 Prognostic significance of TP53 alterations in breast carcinoma. ---
30  1993 Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE). ---
31  1992 Detection of DNA variation in cancer. LOH
32  1992 Genetic changes in breast carcinomas in an Icelandic population. ---
33  1992 No alterations in exon 21 of the RB1 gene in sarcomas and carcinomas of the breast, colon, and lung. LOH, PCR
34  1992 Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE). HPRT, PCR
35  1991 Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. ---